The relevance of magnetic resonance imaging in the era of Alzheimer's disease biomarkers

Marcio Luiz Figueredo Balthazar

doi:10.1055/s-0045-1801863

Arquivos de Neuro-Psiquiatria, Table of Contents

CC BY 4.0 · Arq Neuropsiquiatr 2025; 83(01): s00451801863
DOI: 10.1055/s-0045-1801863

Editorial

The relevance of magnetic resonance imaging in the era of Alzheimer's disease biomarkers

Marcio Luiz Figueredo Balthazar

¹Universidade Estadual de Campinas, Faculdade de Ciências Médicas, Departamento de Neurologia, Campinas SP, Brazil.

› Author Affiliations

Abstract

Bibliographical Record
Marcio Luiz Figueredo Balthazar. The relevance of magnetic resonance imaging in the era of Alzheimer's disease biomarkers. Arq Neuropsiquiatr 2025; 83: s00451801863.
DOI: 10.1055/s-0045-1801863

Full Text

References

References
1 Scheltens P, Leys D, Barkhof F. et al. Atrophy of medial temporal lobes on MRI in “probable” Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 1992; 55 (10) 967-972
2 Enkirch SJ, Traschütz A, Müller A. et al. The ERICA Score: An MR Imaging-based Visual Scoring System for the Assessment of Entorhinal Cortex Atrophy in Alzheimer Disease. Radiology 2018; 288 (01) 226-333
3 Jack Jr CR, Bennett DA, Blennow K. et al; Contributors. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Alzheimers Dement 2018; 14 (04) 535-562
4 Jack Jr CR, Andrews SJ, Beach TG. et al. Revised criteria for the diagnosis and staging of Alzheimer's disease. Nat Med 2024; 30 (08) 2121-2124
5 Socher K, Nunes D, Lopes D, Coutinho A, Faria D, Squarzoni P. et al. Diagnosing preclinical and clinical Alzheimer's disease with visual atrophy scales in clinician practice. Arq Neuropsiq 2025; 83 (01) s00451802960